CenterWatch Email Notification Service

[Guest guest]

Centerwatch Trial Notification Service

New clinical trials have been posted on the CenterWatch web site,

www.centerwatch.com

CenterWatch also provides educational materials on clinical trials for

patients, care-givers and health consumers. To view descriptions of these

resources, please visit

www.centerwatch.com/bookstore/pubs_cons_patientresources.html.

1) Randomized, Multicenter, Open Label, Phase IV Study Evaluating the

Efficacy and Safety of 16-Week Versus 24-Week Treatment with PEGASYS in

Combination with Copegus in Interferon-naove Patients with Chronic Hepatitis

C Genotype 2 or 3 Virus Infection. This study is being conducted in:

- Palo Alto, CA

(http://www.centerwatch.com/patient/studies/stu57272.html)

Additional educational resources that may be of interest to you:

Informed Consent: A Guide to the Risks and Benefits of Volunteering for

Clinical Trials.

http://www.centerwatch.com/bookstore/pubs_cons_infconsent.html

Volunteering for a Clinical Trial, a brief educational pamphlet. If you

would like to order this pamphlet click here:

http://www.centerwatch.com/bookstore/pubs_cons_brochureform.html

You may unsubscribe to this email notification at any time by using the form

at http://www.centerwatch.com/patient/pns/patemail.asp To unsubscribe,

simply enter your email address and click on " Unsubscribe " at the bottom of

the form.

Thank you,

CenterWatch

[Guest guest]

Centerwatch Trial Notification Service

New clinical trials have been posted on the CenterWatch web site,

www.centerwatch.com

CenterWatch also provides educational materials on clinical trials for

patients, care-givers and health consumers. To view descriptions of these

resources, please visit

www.centerwatch.com/bookstore/pubs_cons_patientresources.html.

1) Randomized, Multicenter, Open Label, Phase IV Study Evaluating the

Efficacy and Safety of 16-Week Versus 24-Week Treatment with PEGASYS in

Combination with Copegus in Interferon-naove Patients with Chronic Hepatitis

C Genotype 2 or 3 Virus Infection. This study is being conducted in:

- Palo Alto, CA

(http://www.centerwatch.com/patient/studies/stu57272.html)

Additional educational resources that may be of interest to you:

Informed Consent: A Guide to the Risks and Benefits of Volunteering for

Clinical Trials.

http://www.centerwatch.com/bookstore/pubs_cons_infconsent.html

Volunteering for a Clinical Trial, a brief educational pamphlet. If you

would like to order this pamphlet click here:

http://www.centerwatch.com/bookstore/pubs_cons_brochureform.html

You may unsubscribe to this email notification at any time by using the form

at http://www.centerwatch.com/patient/pns/patemail.asp To unsubscribe,

simply enter your email address and click on " Unsubscribe " at the bottom of

the form.

Thank you,

CenterWatch

[Guest guest]

Centerwatch Trial Notification Service

New clinical trials have been posted on the CenterWatch web site,

www.centerwatch.com

CenterWatch also provides educational materials on clinical trials for

patients, care-givers and health consumers. To view descriptions of these

resources, please visit

www.centerwatch.com/bookstore/pubs_cons_patientresources.html.

1) Randomized, Multicenter, Open Label, Phase IV Study Evaluating the

Efficacy and Safety of 16-Week Versus 24-Week Treatment with PEGASYS in

Combination with Copegus in Interferon-naove Patients with Chronic Hepatitis

C Genotype 2 or 3 Virus Infection. This study is being conducted in:

- Palo Alto, CA

(http://www.centerwatch.com/patient/studies/stu57272.html)

Additional educational resources that may be of interest to you:

Informed Consent: A Guide to the Risks and Benefits of Volunteering for

Clinical Trials.

http://www.centerwatch.com/bookstore/pubs_cons_infconsent.html

Volunteering for a Clinical Trial, a brief educational pamphlet. If you

would like to order this pamphlet click here:

http://www.centerwatch.com/bookstore/pubs_cons_brochureform.html

You may unsubscribe to this email notification at any time by using the form

at http://www.centerwatch.com/patient/pns/patemail.asp To unsubscribe,

simply enter your email address and click on " Unsubscribe " at the bottom of

the form.

Thank you,

CenterWatch

[Guest guest]

Centerwatch Trial Notification Service

New clinical trials have been posted on the CenterWatch web site,

www.centerwatch.com

CenterWatch also provides educational materials on clinical trials for

patients, care-givers and health consumers. To view descriptions of these

resources, please visit

www.centerwatch.com/bookstore/pubs_cons_patientresources.html.

1) Randomized, Multicenter, Open Label, Phase IV Study Evaluating the

Efficacy and Safety of 16-Week Versus 24-Week Treatment with PEGASYS in

Combination with Copegus in Interferon-naove Patients with Chronic Hepatitis

C Genotype 2 or 3 Virus Infection. This study is being conducted in:

- Palo Alto, CA

(http://www.centerwatch.com/patient/studies/stu57272.html)

Additional educational resources that may be of interest to you:

Informed Consent: A Guide to the Risks and Benefits of Volunteering for

Clinical Trials.

http://www.centerwatch.com/bookstore/pubs_cons_infconsent.html

Volunteering for a Clinical Trial, a brief educational pamphlet. If you

would like to order this pamphlet click here:

http://www.centerwatch.com/bookstore/pubs_cons_brochureform.html

You may unsubscribe to this email notification at any time by using the form

at http://www.centerwatch.com/patient/pns/patemail.asp To unsubscribe,

simply enter your email address and click on " Unsubscribe " at the bottom of

the form.

Thank you,

CenterWatch